BioCatalyst

AU-007, Aldesleukin, Avelumab, Nivolumab — catalyst calendar

1 verified catalyst event(s) referencing AU-007, Aldesleukin, Avelumab, Nivolumab, each linked to its official source. Verified as of 2026-10-28.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02-28
in 4mo
ESTIMATED
 READOUT
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Bi
Phase 1/2 · Advanced Solid Tumor, Metastatic Cancer
 Aulos Bioscience, Inc. AU-007, Aldesleukin, Avelumab, Nivolumab ClinicalTrials.gov ↗
✓ Source-checked 2026-10-28
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.